Search Results
Article
Comparative pharmacokinetics and local tolerance of tenofovir alafenamide (TAF) from subcutaneous implant in rabbits, dogs, and macaques
July 19, 2022
Article
Tenofovir Alafenamide for HIV prevention: Review of the proceedings from the Gates foundation long-acting TAF product development meeting
June 01, 2021
Article
Performance and stability of tenofovir alafenamide formulations within subcutaneous biodegradable implants for HIV Pre-Exposure Prophylaxis (PrEP)
November 05, 2020
Article
Predicting pharmacokinetics of a tenofovir alafenamide subcutaneous implant using physiologically based pharmacokinetic modelling
July 22, 2020
Article
Characterization of a reservoir-style implant for sustained release of tenofovir alafenamide (TAF) for HIV pre-exposure prophylaxis (PrEP)
July 04, 2019
Article
Bovine leukemia virus discovered in human blood
April 02, 2019
Article
Development of an End-user Informed Tenofovir Alafenamide (TAF) Implant for Long-acting (LA)-HIV Pre-exposure Prophylaxis (PrEP)
October 01, 2018
Article
A subcutaneous biodegradable implant for sustained delivery of tenofovir alafenamide (TAF) for HIV pre-exposure prophylaxis (PrEP)
October 01, 2018